Prostate Cancer - Results from #25260

Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer - Abstract August 3, 2012

Predicting response to hormonal therapy and survival in men with hormone sensitive metastatic prostate cancer - Abstract August 3, 2012

Prevention of gynecomastia and breast pain caused by androgen deprivation therapy in prostate cancer: Tamoxifen or radiotherapy? - Abstract August 3, 2012

A comprehensive comparison of IMRT and VMAT plan quality for prostate cancer treatment - Abstract August 3, 2012

Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC) - Abstract August 3, 2012

Review of salvage therapy for biochemically recurrent prostate cancer: The role of imaging and rationale for systemic salvage targeted anti-prostate-specific membrane antigen radioimmunotherapy - Abstract August 3, 2012

Androgen deprivation therapy: Past, present and future - Abstract August 3, 2012

Improving the management of patients with prostate cancer receiving long-term androgen deprivation therapy - Abstract August 3, 2012

New developments in castrate-resistant prostate cancer - Abstract August 3, 2012

Drivers for change in the management of prostate cancer - Guidelines and new treatment techniques - Abstract August 3, 2012

Cost-effectiveness analysis of SBRT versus IMRT: An emerging initial radiation treatment option for organ-confined prostate cancer - Abstract August 3, 2012

Cost minimisation analysis: Kilovoltage imaging with automated repositioning versus electronic portal imaging in image-guided radiotherapy for prostate cancer - Abstract August 3, 2012

First case of peritoneal seeding of prostate cancer during robot-assisted laparoscopic radical prostatectomy - Abstract August 3, 2012

Active surveillance failure for prostate cancer: Does the delay in treatment increase the risk of urinary incontinence? - Abstract August 3, 2012

Surgical margin status does not affect overall survival following radical prostatectomy: A single institution experience with expectant management - Abstract August 2, 2012

Variants and unusual patterns of prostate cancer: Clinicopathologic and differential diagnostic considerations - Abstract August 2, 2012

Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the cancer prevention study II nutrition cohort - Abstract August 2, 2012

Prostate cancer pathology audits: Is central pathology review still warranted? - Abstract August 2, 2012

Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer - Abstract August 2, 2012

[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy: Influence of antiandrogen therapy - A preliminary study - Abstract August 2, 2012

Page 1264 of 1437